Lysyl oxidase in cancer research

Future Oncology

Volumn 10, Issue 9, 2014, Pages 1709-1717

  Perryman, Lara ^a   Erler, Janine T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

angiogenesis; cancer; extracellular matrix; lysyl oxidase; metastasis; premetastatic niche; prognostic markers; stroma; therapeutic targets

Indexed keywords

PROTEIN LYSINE 6 OXIDASE; TUMOR SUPPRESSOR PROTEIN;

CANCER GROWTH; CANCER RESEARCH; CELL MIGRATION; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SOLID TUMOR; TUMOR INVASION; ANIMAL; ENZYMOLOGY; MEDICAL RESEARCH; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-LYSINE 6-OXIDASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84906534038     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.39     Document Type: Review

References (65)

1. Fidler IJ. The pathogenesis of cancer metastasis: the ?seed and soil' hypothesis revisited. Nat. Rev. Cancer 3(6), 453-458 (2003
2. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1-32 (2001
3. Maki JM, Kivirikko KI. Cloning and characterization of a fourth human lysyl oxidase isoenzyme. Biochem. J. 355(Pt 2), 381-387 (2001
4. Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res. Treat. 55(2), 127-136 (1999
5. Fong SFT, Dietzsch E, Fong KSK et al. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer 46(7), 644-655 (2007
6. Peinado HC, Del Carmen Iglesias-De La Cruz M, Olmeda D et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24(19), 3446-3458 (2005
7. Holtmeier C, Gorogh T, Beier U et al. Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas. Anticancer Res. 23(3B), 2585-2591 (2003
8. Kim Y, Boyd CD, Csiszar K. A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase. J. Biol. Chem. 270(13), 7176-7182 (1995
9. Jourdan-Le Saux C, Tomsche A, Ujfalusi A, Jia L, Csiszar K. Central nervous system, uterus, heart, and leukocyte expression of the LOXL3 gene, encoding a novel lysyl oxidase-like protein. Genomics 74(2), 211-218 (2001
10. Asuncion L, Fogelgren B, Fong KS, Fong SF, Kim Y, Csiszar K. A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain. Matrix Biol. 20(7), 487-491 (2001
11. Baker AM, Cox TR, Bird D et al. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J. Natl Cancer Inst. 103(5), 407-424 (2011
12. Maki JM, Rasanen J, Tikkanen H et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106(19), 2503-2509 (2002
13. Liu X, Zhao Y, Gao J et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 36(2), 178-182 (2004
14. Trackman PC, Bedell-Hogan D, Tang J, Kagan HM. Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J. Biol. Chem. 267(12), 8666-8671 (1992
15. Erler JT, Bennewith KL, Nicolau M et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440(7088), 1222-1226 (2006
16. Wong CC-L, Gilkes DM, Zhang H et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc. Natl Acad. Sci. USA 108(39), 16369-16374 (2011
17. Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 12(8), 540-552 (2012
18. Taylor MA, Amin JD, Kirschmann DA, Schiemann WP. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-beta signaling in breast cancer cells. Neoplasia 13(5), 406-418 (2011
19. Feres-Filho EJ, Menassa GB, Trackman PC. Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 271(11), 6411-6416 (1996
20. Song YL, Ford JW, Gordon D, Shanley CJ. Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20(4), 982-988 (2000
21. Kenyon K, Contente S, Trackman PC, Tang J, Kagan HM, Friedman RM. Lysyl oxidase and rrg messenger RNA. Science 253(5021), 802-802 (1991
22. Contente S, Kenyon K, Rimoldi D, Friedman RM. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249(4970), 796-798 (1990
23. Giampuzzi M, Botti G, Cilli M et al. Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene. J. Biol. Chem. 276(31), 29226-29232 (2001
24. Sanchez-Morgan N, Kirsch KH, Trackman PC, Sonenshein GE. The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits Beta-catenin transcriptional activity in lung cancer cells. Mol. Cell. Biol. 31(16), 3286-3297 (2011
25. Agra N, Cidre F, Garcia-Garcia L, De La Parra J, Alonso J. Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in ewing sarcoma cells. PLoS ONE 8(6), e66281 (2013
26. Bais MV, Nugent MA, Stephens DN et al. Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS ONE 7(2), (2012
27. Wu G, Guo Z, Chang X et al. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 67(9), 4123-4129 (2007
28. Schmidt H, Semjonow A, Csiszar K, Korsching E, Brandt B, Eltze E. [Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR]. Verh. Deutsch. Ges. Pathol. 91, 302-307 (2007
29. Zhan P, Shen XK, Qian Q et al. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas. Med. Oncol. 29(2), 648-655 (2012
30. Wu M, Min C, Wang X et al. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 67(13), 6278-6285 (2007
31. Kirschmann DA, Seftor EA, Fong SFT et al. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62(15), 4478-4483 (2002
32. Payne SL, Fogelgren B, Hess AR et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65(24), 11429-11436 (2005
33. Payne SL, Hendrix MJ, Kirschmann DA. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex. J. Cell. Biochem. 98(4), 827-837 (2006
34. Levental KR, Yu H, Kass L et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5), 891-906 (2009
35. Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions. Clin. Exp. Metastasis 27(3), 161-172 (2010
36. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119(6), 1420-1428 (2009
37. Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGF-beta paradox to EMT-MET programs. Cancer Lett. 341(1), 30-40 (2013
38. Millanes-Romero A, Herranz N, Perrera V et al. Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition. Mol. Cell 52(5), 746-757 (2013
39. Herranz N, Dave N, Millanes-Romero A et al. Lysyl oxidase-like 2 deaminates lysine 4 in histone H3. Mol. Cell 46(3), 369-376 (2012
40. Schietke R, Warnecke C, Wacker I et al. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J. Biol. Chem. 285(9), 6658-6669 (2010
41. El-Haibi CP, Bell GW, Zhang J et al. Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc. Natl Acad Sci. USA 109(43), 17460-17465 (2012
42. Wiel C, Augert A, Vincent DF et al. Lysyl oxidase activity regulates oncogenic stress response and tumorigenesis. Cell Death Dis. 4, e855 (2013
43. Gao Y, Xiao Q, Ma H et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc. Natl Acad Sci. USA 107(44), 18892-18897 (2010
44. Wilgus M-L, Borczuk AC, Stoopler M et al. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 117(10), 2186-2191 (2011
45. Sakai M, Kato H, Sano A et al. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Ann. Surg. Oncol. 16(9), 2494-2501 (2009
46. Ahn SG, Dong SM, Oshima A et al. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Res. Treat. 141(1), 89-99 (2013
47. Laczko R, Szauter KM, Jansen MK et al. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. Neuropathol. Appl. Neurobiol. 33(6), 631-643 (2007
48. Le QT, Kong C, Lavori PW et al. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 69(1), 167-175 (2007
49. Peng L, Ran YL, Hu H et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis 30(10), 1660-1669 (2009
50. Erler JT, Bennewith KL, Cox TR et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15(1), 35-44 (2009
51. Chang J, Nicolau M, Cox TR et al. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling. Breast Cancer Res. 15(4), R67 (2013
52. Cano A, Santamaria PG, Moreno-Bueno G. LOXL2 in epithelial cell plasticity and tumor progression. Future Oncol. 8(9), 1095-1108 (2012
53. Barker HE, Chang J, Cox TR et al. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 71(5), 1561-1572 (2011
54. Baker AM, Bird D, Lang G, Cox TR, Erler JT. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene 2(14), 1863-1868 (2012
55. Kaplan RN, Riba RD, Zacharoulis S et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069), 820-827 (2005
56. Cox TR, Bird D, Baker A-M et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 73(6), 1721-1732 (2013
57. Pickup MW, Laklai H, Acerbi I et al. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor beta-deficient mouse mammary carcinomas. Cancer Res. 73(17), 5336-5346 (2013
58. Barker HE, Bird D, Lang G, Erler JT. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling. Mol. Cancer Res. 11(11), 1425-1436 (2013
59. Baker A-M, Bird D, Welti JC et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res. 73(2), 583-594 (2012
60. Osawa T, Ohga N, Akiyama K et al. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis. Br. J. Cancer 109(8), 2237-2247 (2013
61. Zaffryar-Eilot S, Marshall D, Voloshin T et al. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours. Carcinogenesis 34(10), 2370-2379 (2013
62. Pez F, Dayan FDR, Durivault JR et al. The HIF-1alpha inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 71(5), 1647-1657 (2011
63. Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am. J. Pathol. 183(4), 1293-1305 (2013
64. Kanapathipillai M, Mammoto A, Mammoto T et al. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. Nano Lett. 12(6), 3213-3217 (2012
65. Barry-Hamilton V, Spangler R, Marshall D et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat. Med. 16(9), 1009-1017 (2010).